Racecadotril (BioDeep_00000275619)
natural product
代谢物信息卡片
Racecadotril (Acetorphan)
化学式: C21H23NO4S (385.13477180000007)
中文名称: 消旋卡多曲
谱图信息:
最多检出来源 Escherichia coli(natural_products) 66.67%
分子结构信息
SMILES: C1=CC=C(C=C1)COC(CNC(C(CSC(=O)C)CC2=CC=CC=C2)=O)=O
InChI: InChI=1S/C21H23NO4S/c1-16(23)27-15-19(12-17-8-4-2-5-9-17)21(25)22-13-20(24)26-14-18-10-6-3-7-11-18/h2-11,19H,12-15H2,1H3,(H,22,25)
描述信息
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent
D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
同义名列表
2 个代谢物同义名
数据库引用编号
10 个数据库交叉引用编号
- ChEBI: CHEBI:91508
- KEGGdrug: D08464
- PubChem: 107751
- DrugBank: DB11696
- ChEMBL: CHEMBL2103772
- CAS: 81110-73-8
- MoNA: FiehnHILIC002290
- MoNA: FiehnHILIC000725
- MoNA: CCMSLIB00000078496
- PMhub: MS000008365
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Lan Li, Chenlin Shen, Lian Tang, Yanxia Yu, Qin Zhou, Xiaohui Huang, Sudong Xue. Determination of thiorphan, a racecadotril metabolite, in human plasma by LC-MS/MS and its application to a bioequivalence study in Chinese subjects
.
International journal of clinical pharmacology and therapeutics.
2020 Jul; 58(7):408-414. doi:
10.5414/cp203588. [PMID: 32352368] - David W Griggs, Michael J Prinsen, Jonathan Oliva, Mary A Campbell, Stacy D Arnett, Deena Tajfirouz, Peter G Ruminski, Ying Yu, Brian R Bond, Yuhua Ji, Georg Neckermann, Robert K M Choy, Eugenio de Hostos, Marvin J Meyers. Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea.
The Journal of pharmacology and experimental therapeutics.
2016 May; 357(2):423-31. doi:
10.1124/jpet.115.231167. [PMID: 26907621] - Raphaëlle Pelc, Sébastien Redant, Sébastien Julliand, Juan Llor, Mathie Lorrot, Rianne Oostenbrink, Vincent Gajdos, François Angoulvant. Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland.
BMC pediatrics.
2014 May; 14(?):125. doi:
10.1186/1471-2431-14-125. [PMID: 24884619] - Philippe Lehert, Gérard Chéron, Guillermo Alvarez Calatayud, Jean-Pierre Cézard, Pedro Gutierrez Castrellón, José-Manuel Meléndez Garcia, Mar Santos, M R Savitha. Racecadotril for childhood gastroenteritis: an individual patient data meta-analysis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
2011 Sep; 43(9):707-13. doi:
10.1016/j.dld.2011.03.001. [PMID: 21514257] - J-P Lee, K-C Cheng, H-H Chung, H-T Wu, C-T Chen, J-T Cheng. Inhibition of insulin degrading enzyme by racecadotril in the brain of Wistar rats.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
2011 Jun; 43(7):489-93. doi:
10.1055/s-0031-1277183. [PMID: 21557151] - H T Wu, C K Chang, K C Cheng, C H Chang, C H Yeh, J T Cheng. Increase of plasma insulin by racecadotril, an inhibitor of enkephalinase, in Wistar rats.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
2010 Apr; 42(4):261-7. doi:
10.1055/s-0029-1246190. [PMID: 20143290] - Fan Xu, Lingli Yang, Guili Xu. A rapid and validated HPLC method to quantify racecadotril metabolite, thiorphan, in human plasma using solid-phase extraction.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2008 Jan; 861(1):130-5. doi:
10.1016/j.jchromb.2007.11.038. [PMID: 18083074] - Yu Xu, Jinchang Huang, Fei Liu, Shu Gao, Qingxiang Guo. Quantitative analysis of racecadotril metabolite in human plasma using a liquid chromatography/tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2007 Jun; 852(1-2):101-7. doi:
10.1016/j.jchromb.2006.12.041. [PMID: 17241825] - Giovanni Sansoè, Manuela Aragno, Raffaella Mastrocola, Francesca Restivo, Giulio Mengozzi, Antonina Smedile, Floriano Rosina, Oliviero Danni, Maurizio Parola, Mario Rizzetto. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?.
Journal of hepatology.
2005 Nov; 43(5):791-8. doi:
10.1016/j.jhep.2005.04.017. [PMID: 16085334] - Anthony C Sulpizio, Mark A Pullen, Richard M Edwards, David P Brooks. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
The Journal of pharmacology and experimental therapeutics.
2004 Jun; 309(3):1141-7. doi:
10.1124/jpet.103.064105. [PMID: 14769834] - S Huighebaert, F Awouters, G N J Tytgat. Racecadotril versus loperamide: antidiarrheal research revisited.
Digestive diseases and sciences.
2003 Feb; 48(2):239-50. doi:
10.1023/a:1021989606317. [PMID: 12643598] - François Piquard, Ruddy Richard, Anne Charloux, Stephane Doutreleau, Thierry Hannedouche, Gabrielle Brandenberger, Bernard Geny. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.
Journal of applied physiology (Bethesda, Md. : 1985).
2002 Aug; 93(2):569-75. doi:
10.1152/japplphysiol.00027.2002. [PMID: 12133866] - E Salazar-Lindo, J Santisteban-Ponce, E Chea-Woo, M Gutierrez. Racecadotril in the treatment of acute watery diarrhea in children.
The New England journal of medicine.
2000 Aug; 343(7):463-7. doi:
10.1056/nejm200008173430703. [PMID: 10944563] - G Freyer, P Rougier, R Bugat, J P Droz, M Marty, H Bleiberg, D Mignard, L Awad, P Herait, S Culine, V Trillet-Lenoir. Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups.
British journal of cancer.
2000 Aug; 83(4):431-7. doi:
10.1054/bjoc.2000.1303. [PMID: 10945486] - Y Takeda, S Inaba, K Furukawa, A Fujimura, I Miyamori, H Mabuchi. Effects of chronic neutral endopeptidase inhibition in rats with cyclosporine-induced hypertension.
Journal of hypertension.
2000 Jul; 18(7):927-33. doi:
10.1097/00004872-200018070-00015. [PMID: 10930191] - P Solter, D Sisson, W Thomas, L Goetze. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
The Journal of pharmacology and experimental therapeutics.
2000 Jun; 293(3):989-95. doi:
NULL. [PMID: 10869402] - T Maertins, E von Keutz, L Goetze. Acute, subchronic, and chronic toxicity of ecadotril in dogs.
American journal of veterinary research.
2000 Apr; 61(4):425-9. doi:
10.2460/ajvr.2000.61.425. [PMID: 10772108] - N B Olivier, S M Kutas, S Beals, B Hanson, S Windram. Short-term effects of ecadotril in dogs with induced congestive heart failure.
American journal of veterinary research.
2000 Mar; 61(3):333-8. doi:
10.2460/ajvr.2000.61.333. [PMID: 10714529] - C M O'Connor, W A Gattis, M Gheorghiade, C B Granger, J Gilbert, J M McKenney, F C Messineo, J C Burnett, S D Katz, U Elkayam, E K Kasper, S Goldstein, R J Cody, B M Massie. A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study.
American heart journal.
1999 Dec; 138(6 Pt 1):1140-8. doi:
10.1016/s0002-8703(99)70081-5. [PMID: 10577446] - A M Duncan, G M James, F Anastasopoulos, A Kladis, T A Briscoe, D J Campbell. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
The Journal of pharmacology and experimental therapeutics.
1999 Apr; 289(1):295-303. doi:
NULL. [PMID: 10087017] - H Ito, M Majima, S Nakajima, I Hayashi, M Katori, T Izumi. Effect of prolonged administration of a urinary kinase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats.
British journal of pharmacology.
1999 Feb; 126(3):613-20. doi:
10.1038/sj.bjp.0702340. [PMID: 10188971] - D J Campbell, F Anastasopoulos, A M Duncan, G M James, A Kladis, T A Briscoe. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
The Journal of pharmacology and experimental therapeutics.
1998 Nov; 287(2):567-77. doi:
NULL. [PMID: 9808682] - M Kimura, K Umemura, K Ohashi, M Nakashima. Effect of ecadotril, a neutral endopeptidase inhibitor, on myocardial hypertrophy in the rat aortic insufficiency model.
The Canadian journal of cardiology.
1998 Jan; 14(1):63-8. doi:
NULL. [PMID: 9487275] - T A Hinterleitner, W Petritsch, G Dimsity, H Berard, J M Lecomte, G J Krejs. Acetorphan prevents cholera-toxin-induced water and electrolyte secretion in the human jejunum.
European journal of gastroenterology & hepatology.
1997 Sep; 9(9):887-91. doi:
10.1097/00042737-199709000-00012. [PMID: 9355788] - J P Stasch, C Hirth-Dietrich, D Ganten, M Wegner. Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene.
American journal of hypertension.
1996 Aug; 9(8):795-802. doi:
10.1016/0895-7061(96)00099-4. [PMID: 8862226] - M Wegner, C Hirth-Dietrich, J P Stasch. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Cardiovascular research.
1996 Jun; 31(6):891-8. doi:
NULL. [PMID: 8759244] - L Beaugerie, P Baumer, S Chaussade, H Berard, W Rozenbaum, G Pialoux, Y Le Quintrec, J C Schwartz, J M Lecomte. Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.
European journal of gastroenterology & hepatology.
1996 May; 8(5):485-9. doi:
". [PMID: 8804878] - C A Fink, Y Qiao, C J Berry, Y Sakane, R D Ghai, A J Trapani. New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
Journal of medicinal chemistry.
1995 Dec; 38(26):5023-30. doi:
10.1021/jm00026a009. [PMID: 8544178] - B Favrat, M Burnier, J Nussberger, J M Lecomte, R Brouard, B Waeber, H R Brunner. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Journal of hypertension.
1995 Jul; 13(7):797-804. doi:
NULL. [PMID: 7594444] - J P Stasch, A Knorr, M Wegner, C Hirth-Dietrich. Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats.
Hypertension research : official journal of the Japanese Society of Hypertension.
1995 Jun; 18(2):137-43. doi:
10.1291/hypres.18.137. [PMID: 7584920] - F Schmitt, F Martinez, A Ikeni, C Savoiu, S Natov, K Laborde, B Lacour, J P Grünfeld, T Hannedouche. Acute renal effects of neutral endopeptidase inhibition in humans.
The American journal of physiology.
1994 Jul; 267(1 Pt 2):F20-7. doi:
10.1152/ajprenal.1994.267.1.f20. [PMID: 7519405] - D M Lambert, F Mergen, J H Poupaert, P Dumont. Analgesic potency of S-acetylthiorphan after intravenous administration to mice.
European journal of pharmacology.
1993 Oct; 243(2):129-34. doi:
10.1016/0014-2999(93)90371-n. [PMID: 8276061] - J C Dussaule, C Michel, M N Peraldi, J M Lecomte, C Gros, F Mignon, R Ardaillou. Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.
Clinical science (London, England : 1979).
1993 Jan; 84(1):31-9. doi:
10.1042/cs0840031. [PMID: 8382131] - M C Fournié-Zaluski, P Coric, S Turcaud, L Bruetschy, E Lucas, F Noble, B P Roques. Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation.
Journal of medicinal chemistry.
1992 Apr; 35(7):1259-66. doi:
10.1021/jm00085a013. [PMID: 1348542] - J Varin, D Duboc, S Weber, J Fouchard, J C Schwartz, M Muffat-Joly, F Guérin. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
Archives des maladies du coeur et des vaisseaux.
1991 Oct; 84(10):1465-71. doi:
NULL. [PMID: 1662033] - C Gros, N Noël, A Souque, J C Schwartz, D Danvy, J C Plaquevent, L Duhamel, P Duhamel, J M Lecomte, J Bralet. Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
Proceedings of the National Academy of Sciences of the United States of America.
1991 May; 88(10):4210-4. doi:
10.1073/pnas.88.10.4210. [PMID: 1851998] - J C Dussaule, J D Grangé, J P Wolf, J M Lecomte, C Gros, J C Schwartz, F Bodin, R Ardaillou. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
The Journal of clinical endocrinology and metabolism.
1991 Mar; 72(3):653-9. doi:
10.1210/jcem-72-3-653. [PMID: 1847706] - C Gros, A Souque, J C Schwartz. Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: role of enkephalinase (EC 3.4.24.11).
Neuropeptides.
1990 Sep; 17(1):1-5. doi:
10.1016/0143-4179(90)90133-j. [PMID: 2148814] - J M Lecomte, P Baumer, C Lim, J Duchier, A Cournot, J C Dussaule, R Ardaillou, C Gros, B Chaignon, A Souque. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.
European journal of pharmacology.
1990 Apr; 179(1-2):65-73. doi:
10.1016/0014-2999(90)90402-r. [PMID: 2163851] - C Gros, A Souque, J C Schwartz. Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).
European journal of pharmacology.
1990 Apr; 179(1-2):45-56. doi:
10.1016/0014-2999(90)90400-z. [PMID: 2142086] - J Bralet, C Mossiat, J M Lecomte, S Charpentier, C Gros, J C Schwartz. Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.
European journal of pharmacology.
1990 Apr; 179(1-2):57-64. doi:
10.1016/0014-2999(90)90401-q. [PMID: 2142087] - J C Kahn, M Patey, J L Dubois-Rande, P Merlet, A Castaigne, C Lim-Alexandre, J M Lecomte, D Duboc, C Gros, J C Schwartz. Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure.
Lancet (London, England).
1990 Jan; 335(8681):118-9. doi:
10.1016/0140-6736(90)90595-v. [PMID: 1967410] - C Gros, A Souque, J C Schwartz, J Duchier, A Cournot, P Baumer, J M Lecomte. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
Proceedings of the National Academy of Sciences of the United States of America.
1989 Oct; 86(19):7580-4. doi:
10.1073/pnas.86.19.7580. [PMID: 2529543] - L Jivegård, H Pollard, J Moreau, J C Schwartz, A Thune, J Svanvik. Naloxone-reversible inhibition of gall-bladder mucosal fluid secretion in experimental cholecystitis in the cat by acetorphan, an enkephalinase inhibitor.
Clinical science (London, England : 1979).
1989 Jul; 77(1):49-54. doi:
10.1042/cs0770049. [PMID: 2758762] - S De la Baume, F Brion, M Dam Trung Tuong, J C Schwartz. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
The Journal of pharmacology and experimental therapeutics.
1988 Nov; 247(2):653-60. doi:
NULL. [PMID: 3183961] - M G Spillantini, P Geppetti, M Fanciullacci, S Michelacci, J M Lecomte, F Sicuteri. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
European journal of pharmacology.
1986 Jun; 125(1):147-50. doi:
10.1016/0014-2999(86)90094-4. [PMID: 3015640]